← Open Payments lookup

GHODRAT SHOLEVAR: Open Payments

NPI 1649324955 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,242 in 50 payments from 9 companies in 2025. Trend: 2023 $534 · 2024 $671 · 2025 $1,242

Food & beverage: $1,242
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.13$370
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$224
ABBVIE INC.10$218
Lundbeck LLC6$151
Janssen Pharmaceuticals, Inc4$90
Otsuka America Pharmaceutical, Inc.3$67
Almatica Pharma LLC2$51
E.R. Squibb & Sons, L.L.C.2$50
Alkermes, Inc.1$19

Products named: INGREZZA, CAPLYTA, REXULTI, VRAYLAR, INVEGA SUSTENNA, LOREEV XR, COBENFY, ARISTADA.

Industry payments across PA — which companies pay providers there.